Compounds > quinazolines
Page last updated: 2024-08-21

quinazolines and transferrin

quinazolines has been researched along with transferrin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brychzy, A; de Paulsen, N; Fournier, MC; Gnarra, JR; Klausner, RD; Lee, S; Pause, A1
Bereczky, B; Nishimura, Y; Ono, M1
Chen, Y; Gibson, SB; Henson, ES; Ma, S1

Other Studies

3 other study(ies) available for quinazolines and transferrin

ArticleYear
Role of transforming growth factor-alpha in von Hippel--Lindau (VHL)(-/-) clear cell renal carcinoma cell proliferation: a possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis.
    Proceedings of the National Academy of Sciences of the United States of America, 2001, Feb-13, Volume: 98, Issue:4

    Topics: Adenocarcinoma, Clear Cell; Cell Division; Cell Hypoxia; Enzyme Inhibitors; ErbB Receptors; Gene Expression Regulation; Genes, Tumor Suppressor; Growth Substances; Humans; Insulin; Kidney Neoplasms; Ligases; Oligodeoxyribonucleotides, Antisense; Proteins; Quinazolines; Selenium; Transferrin; Transforming Growth Factor alpha; Tumor Cells, Cultured; Tumor Suppressor Proteins; Tyrphostins; Ubiquitin-Protein Ligases; von Hippel-Lindau Disease; Von Hippel-Lindau Tumor Suppressor Protein

2001
The EGFR inhibitor gefitinib suppresses ligand-stimulated endocytosis of EGFR via the early/late endocytic pathway in non-small cell lung cancer cell lines.
    Histochemistry and cell biology, 2007, Volume: 127, Issue:5

    Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cathepsin D; Cell Line, Tumor; Cell Membrane; Drug Resistance, Neoplasm; Endocytosis; Endosomes; Epidermal Growth Factor; ErbB Receptors; Gefitinib; Humans; Lysosomal Membrane Proteins; Lysosomes; Microscopy, Fluorescence; Protein Transport; Qa-SNARE Proteins; Quinazolines; Receptors, Scavenger; Signal Transduction; Transferrin

2007
Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells.
    Cell death & disease, 2016, 07-21, Volume: 7

    Topics: Antineoplastic Agents; Cation Transport Proteins; Cell Death; Cell Line, Tumor; Cyclohexylamines; Deferoxamine; Drug Synergism; Female; Ferritins; Gene Expression Regulation; Humans; Imidazoles; Indoles; Iron; Iron Chelating Agents; Lapatinib; Lysosomes; MCF-7 Cells; Phenylenediamines; Protein Kinase Inhibitors; Quinazolines; Reactive Oxygen Species; Receptors, Transferrin; Signal Transduction; Spiro Compounds; Transcription Factors; Transferrin

2016